Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Compass Therapeutics Inc (CMPX)

Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Compass Therapeutics Inc 80 GUEST STREET SUITE 601 BOSTON MA 02135 USA

www.compasstherapeutics.com P: 617-500-8099

Description:

Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.

Key Statistics

Overview:

Market Capitalization, $K 203,632
Enterprise Value, $K 179,402
Shares Outstanding, K 137,589
Annual Sales, $ 0 K
Annual Net Income, $ -42,490 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,420 K
EBIT, $ -50,370 K
EBITDA, $ -51,710 K
60-Month Beta 0.78
% of Insider Shareholders 30.00%
% of Institutional Shareholders 68.43%
Float, K 96,312
% Float 70.00%
Short Volume Ratio 0.36

Growth:

1-Year Return -45.39%
3-Year Return -78.86%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 03/21/24
Latest Earnings Date 05/02/24 [--]
Earnings Per Share ttm -0.34
EPS Growth vs. Prev Qtr -37.50%
EPS Growth vs. Prev Year -10.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CMPX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.06%
Return-on-Assets % -24.49%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.30
Book Value/Share 1.17
Interest Coverage -2.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar